Skip to main content

Together we are beating cancer

Donate now

Tim Gunn

Tim is a senior digital news officer at Cancer Research UK. He started writing about science after studying English literature at Cambridge and magazine journalism at City, University of London. Before joining the digital news team in August 2022, he was a journalist and medical magazine editor.
Showing 12 out of 70 results
Lab-grown bowel cancer cells seen through a microscope. They are colour-enhanced and appear blue.

A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists.  A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists. 

by Tim Gunn | News | 30 January 2025

30 January 2025

A group of three Cancer Research UK scientists Group of researchers looking at a data file in a lab

A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.   A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.  

by Tim Gunn | News | 28 January 2025

28 January 2025

A microscope image showing immune cells in bowel cancer.

A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects. A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects.

by Sadaf Shafaghmotlagh, Tim Gunn | Analysis | 27 January 2025

27 January 2025

Salmonella bacteria (rod-shaped organisms coloured blue) in a bowel cancer tumour (coloured beige). The bacteria looks like it is rushing into a hole in the tumour tissue.

Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once. Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once.

by Tim Gunn, Fiona MacLeod | News | 23 January 2025

23 January 2025

A man in a bathroom opening a bowel cancer screening test kit (FIT kit) from NHS England.

NHS England's bowel cancer screening is expanding to 50 and 52-year-olds. Everyone 50 to 74 will now receive a FIT kit every two years. NHS England's bowel cancer screening is expanding to 50 and 52-year-olds. Everyone 50 to 74 will now receive a FIT kit every two years.

by Tim Gunn | News | 14 January 2025

14 January 2025

A group of postgraduate researchers working in a laboratory at the University of Nottingham.
  • Charity News
  • Health & Medicine
  • Science & Technology

Getting ahead of cancer: our 2024 research highlights

The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months. The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months.

by Sadaf Shafaghmotlagh, Tim Gunn | In depth | 17 December 2024

17 December 2024

Dr Yin Cao and a colleague looking at data about cancer incidence.

Rising rates of early-onset bowel cancer are a “global phenomenon”, and some of the steepest increases are happening in England, according to a major new paper we helped fund. Rising rates of early-onset bowel cancer are a “global phenomenon”, and some of the steepest increases are happening in England, according to a major new paper we helped fund.

by Tim Gunn | News | 11 December 2024

11 December 2024

A cancer cell dividing.

With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer. With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer.

by Tim Gunn | News | 6 December 2024

6 December 2024

The capsule sponge shown in pill form and sponge form. Both are black and attached to a white thread.

Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme. Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme.

by Tim Gunn | Analysis | 28 November 2024

28 November 2024

Two Cancer Research UK researchers working at a lab bench.

We're launching our updated Equality, Diversity and Inclusion (EDI) strategy, outlining our renewed ambitions for the next five years. It will play a vital role in helping us achieve our vision of a world where everybody lives longer, better lives, free from the fear of cancer. We're launching our updated Equality, Diversity and Inclusion (EDI) strategy, outlining our renewed ambitions for the next five years. It will play a vital role in helping us achieve our vision of a world where everybody lives longer, better lives, free from the fear of cancer.

by Tim Gunn | News | 20 November 2024

20 November 2024

Healthy lungs drawn as if they were an upside-down tree.

Almost 668,000 lives have been saved from lung cancer in the UK since the 1970s, according to our latest analysis. We're working to save more. Almost 668,000 lives have been saved from lung cancer in the UK since the 1970s, according to our latest analysis. We're working to save more.

by Tim Gunn | News | 14 November 2024

14 November 2024

broken cigarette on yellow background

Varenicline has been shown to work as well as vapes and better than nicotine patches. It could prevent 9,500 deaths in the next five years. Varenicline has been shown to work as well as vapes and better than nicotine patches. It could prevent 9,500 deaths in the next five years.

by Tim Gunn | News | 12 November 2024

12 November 2024